SEC
Filing

SEC Filing Details

Document Details

Form
Filing Date
Sep 11, 2019
Document Date
Sep 9, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Altimmune
Issuer
ALTIMMUNE, INC.
Filer
Harris Matthew Scott
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe